TG Therapeutics, Inc.
TGTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $23 | $13 | -$198 | -$348 |
| Dep. & Amort. | $0 | $0 | $1 | $0 |
| Deferred Tax | $0 | $0 | $0 | $1 |
| Stock-Based Comp. | $43 | $38 | $19 | $61 |
| Change in WC | -$109 | -$85 | -$2 | -$12 |
| Other Non-Cash | $3 | $2 | $4 | $2 |
| Operating Cash Flow | -$41 | -$31 | -$176 | -$296 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | $0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $20 | -$0 |
| Inv. Purchases | -$312 | -$147 | -$107 | -$56 |
| Inv. Sales/Matur. | $311 | $96 | $87 | $56 |
| Other Inv. Act. | $0 | $0 | -$20 | $0 |
| Investing Cash Flow | -$1 | -$51 | -$20 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $137 | $25 | -$1 | $40 |
| Stock Issued | $0 | $46 | $1 | $2 |
| Stock Repurch. | -$9 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $1 | $0 | -$1 |
| Financing Cash Flow | $129 | $73 | -$0 | $41 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $87 | -$9 | -$197 | -$255 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $94 | $104 | $300 | $555 |
| End Cash | $181 | $94 | $104 | $300 |
| Free Cash Flow | -$41 | -$31 | -$176 | -$296 |